HELION BIOTECH ApS: Financial statements 2020
CVR: 31758106
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 34,102 and a net result of DKK 28,186 compared with DKK -22,792 the year before. Equity in the 2020 report amounted to DKK 208,829. The solvency ratio was 39%.
- Gross Profit
- DKK 34,102
- Profit/Loss
- DKK 28,186
- Equity
- DKK 208,829
- Total Assets
- DKK 534,984
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 34 t. | 28 t. | 209 t. | - |
| 2019 | - | -18 t. | -23 t. | 181 t. | - |
| 2018 | - | 5 mio. | 3.9 mio. | 563 t. | - |
| 2017 | - | -12 t. | -14 t. | 218 t. | - |
| 2016 | - | -82 t. | -84 t. | 932 t. | - |
Official annual report
How creditworthy is HELION BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
HELION BIOTECH ApS has published its annual report for 2019. Gross profit came to DKK -18,093, and the net result was DKK -22,792.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.